FUJIFILM’S SYNAPSE VNA ACHIEVES GLOBAL MILESTONE, SERVING MORE THAN 1000 FACILITIES WORLDWIDE
Stamford, CT, November 1, 2016 – The TeraMedica Division of FUJIFILM Medical Systems U.S.A., Inc., a leading provider of diagnostic imaging products and medical informatics solutions, today announced an important business milestone in serving global healthcare providers. The company’s Synapse VNA, an enterprise-wide medical information and image management solution, now manages nearly 10 billion objects – data and images – via 350 installations serving more than 1000 facilities worldwide.
“The sheer scope and reach of Synapse VNA is undeniable and reflects Fujifilm’s strong foothold in the VNA marketplace,” said Greg Strowig, Vice President, TeraMedica Division of FUJIFILM Medical Systems U.S.A., Inc., “Large healthcare organizations around the world continue to rely on us for our unsurpassed experience in this field and our understanding of how technology must link back to better patient care.”
Synapse VNA manages all enterprise clinical imaging content, both DICOM and non-DICOM, using the most scalable single storage solution available. Equipped with advanced life cycle management tools, it offers organizations the ability to secure and control of all image data across the enterprise. A true enterprise imaging solution, Synapse VNA allows users to connect imaging content from more specialty clinical areas than any other system. It also features an enterprise viewer that provides a single patient-centric view across the entire continuum of care.
Mayo Clinic began using Synapse VNA in production in August of 2003—successfully migrating a decade of data. Today, Synapse VNA manages over 5.5 billion objects for the world-renowned healthcare institution including content from 28 clinical and research departments, 3 major clinics, and the Mayo Health System which serves some 70 communities in the Midwest and Georgia
New South Wales Health completed a statewide rollout of Synapse VNA in 2013, gaining efficiencies and improved patient care. Today, Fujifilm manages over 800 million objects for approximately 200 hospitals and clinics statewide—making it the largest production VNA in the world.
With Synapse VNA, diagnostic images and reports from anywhere in the state can follow the patient. They are automatically accessible in the local RIS, PACS, or EMR of any New South Wales facility—regardless of the vendor.
“Being able to share images of a remote-located patient with a specialist in a major specialty care facility before deciding whether to transfer the patient via air, for example, is a big improvement and advantage,” said Strowig. “That translates into better patient care and lower costs which were two of the original objectives when implementing a statewide image repository solution.”
FUJIFILM Medical Systems U.S.A., Inc. is a leading provider of diagnostic imaging products and medical informatics solutions to meet the needs of healthcare facilities today and well into the future. From an unrivaled selection of digital x-ray systems, to the Synapse® brand of PACS, RIS and cardiovascular products, to advanced women’s health imaging systems, Fujifilm has products that are ideal for any size imaging environment. The Endoscopy Division of FUJIFILM Medical Systems U.S.A., Inc. supplies high quality, technologically advanced FUJINON brand endoscopes to the medical market. The TeraMedicaDivision delivers healthcare informatics, and is the leading provider of vendor neutral, enterprise-wide solutions for unrestricted medical image management. FUJIFILM Medical Systems U.S.A., Inc. is headquartered in Stamford, CT. For more information please visit: healthcaresolutions-us.fujifilm.com and www.fujifilmendoscopy.com.
FUJIFILM Holdings Corporation, Tokyo, Japan brings continuous innovation and leading-edge products to a broad spectrum of industries, including: healthcare, with medical systems, pharmaceuticals and cosmetics; graphic systems; highly functional materials, such as flat panel display materials; optical devices, such as broadcast and cinema lenses; digital imaging; and document products. These are based on a vast portfolio of chemical, mechanical, optical, electronic, software and production technologies. In the year ended March 31, 2015, the company had global revenues of $20.8 billion, at an exchange rate of 120 yen to the dollar. Fujifilm is committed to environmental stewardship and good corporate citizenship. For more information, please visit: www.fujifilmholdings.com.
All product and company names herein may be trademarks of their registered owners.